Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial
Constantin‐Cristian Topriceanu(University College London), Carolyn Y. Ho(Brigham and Women's Hospital), James Moon(University of Michigan), Charles E. Canter(St. Louis Children's Hospital), Anna Axelsson Raja(Copenhagen University Hospital), Christine E. Seidman(Harvard University), Christoffer Rasmus Vissing(Copenhagen University Hospital), Ivan Wilmot(Cincinnati Children's Hospital Medical Center), Usman A. Tahir(Beth Israel Deaconess Medical Center), Joseph W. Rossano(Children's Hospital of Philadelphia), Alexandre C. Pereira(University of Washington), Anjali Owens(University of Pennsylvania), Amit R. Patel(University of Virginia), Jonathan H. Soslow(Vanderbilt University Medical Center), Gabriella Captur(Royal Free London NHS Foundation Trust), Henning Bundgaard(Copenhagen University Hospital), Neal K. Lakdawala(Brigham and Women's Hospital), Matthew T. Wheeler(Stanford University), Kenneth Zahka(Cleveland Clinic), Jason R. Becker(University of Pittsburgh), Matthew R.G. Taylor(University of Colorado Anschutz Medical Campus), Luisa Mestroni(University of Colorado Anschutz Medical Campus), Sharlene M. Day(University of Pennsylvania), Richard G. Bach(Washington University in St. Louis), Steven D. Colan(Boston Children's Hospital), Mark W. Russell(Andover Eye Associates), Anne M. Murphy(Johns Hopkins University)
Cited by 3
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k